scispace - formally typeset
K

Karin Kast

Researcher at Dresden University of Technology

Publications -  113
Citations -  8347

Karin Kast is an academic researcher from Dresden University of Technology. The author has contributed to research in topics: Breast cancer & Population. The author has an hindex of 36, co-authored 108 publications receiving 6347 citations. Previous affiliations of Karin Kast include Helmholtz-Zentrum Dresden-Rossendorf & Mayo Clinic.

Papers
More filters
Journal ArticleDOI

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Karoline Kuchenbaecker, +67 more
- 20 Jun 2017 - 
TL;DR: To estimate age-specific risks of breast, ovarian, and contralateral breast cancer for mutation carriers and to evaluate risk modification by family cancer history and mutation location, a large cohort study recruited in 1997-2011 provides estimates of cancer risk based on BRCA1 and BRCa2 mutation carrier status.
Journal ArticleDOI

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Nasim Mavaddat, +132 more
TL;DR: Pathologic characteristics of BRCA1 and BRCa2 tumors may be useful for improving risk-prediction algorithms and informing clinical strategies for screening and prophylaxis.
Journal ArticleDOI

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Fergus J. Couch, +261 more
- 27 Mar 2013 - 
TL;DR: It is estimated that the breast cancer lifetime risks for the5% of BRCA1 carriers at lowest risk are 28%–50% compared to 81%–100% for the 5% at highest risk, and the ovarian cancer lifetime risk is 63% or higher, based on the known cancer risk-modifying loci.
Journal ArticleDOI

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Timothy R. Rebbeck, +261 more
- 07 Apr 2015 - 
TL;DR: In this paper, the relationship between specific mutations in BRCA1 and cancer risk has been investigated and limited information about the relationship has been available about specific mutations for specific mutations.